跳至主要内容
临床试验/NCT05037539
NCT05037539已完成1 期

Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain in Gynecologic Cancer Patients With Chronic Cancer Pain : A Randomized Double Blind Controlled Trial

Rajavithi Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年6月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
20
试验地点
1
主要终点
Pain score

研究概览

简要总结

Randomized control trial that to comparison the efficacy of injectable fentanyl in sublingual route versus oral morphine syrup for breakthrough pain in gynecologic cancer patients with chronic cancer pain Primary outcome : to measure pain score after drug is given

详细描述

objective; To comparison the efficacy of injectable fentanyl in sublingual route versus oral morphine syrup for breakthrough pain in gynecologic cancer patients with chronic cancer pain Population : gynecologic cancer patients with chronic cancer pain that use opioid drug for basal pain and had experienced of breakthrough pain cancer in Rajavithi hospital sample size : 20 person/group Method ; Randomized control trial , Prospective Intervention : group A : injectable fentanyl in sublingual , group B : oral morphine syrup Primary outcome : to measure pain score after drug is given at 5, 15, 30, 45, 60 and 120 min secondary outcome : to record side effect of drug is given at 5, 15, 30, 45, 60 and 120 min Statistical method

  • Categorical data = Chi-square test or Fishers' exact test
  • Continuous data : comparison with Student t-test in normal deviation data and Man-Whitney U- test in abnormal deviation data • Analytical data with Pearson's correlation, Linear regression or Binary Logistic regression, Repeated Measures ANOVA with OR (95%CI) and p-value <0.05

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

性别
Female
接受健康志愿者

入选标准

  • Gynecologic cancer patients with chronic cancer pain that use opioid drug for basal pain

排除标准

  • allergy in fentanyl or morphine
  • abnormal cognitive function patient

研究组 & 干预措施

Injectable Fentanyl in Sublingual Route

Experimental

Injectable Fentanyl in Sublingual Route that given after the first time Breakthrough Pain is occurred 50 mcg in sublingual route

干预措施: Fentanyl Citrate 50Mcg/Ml Inj_#1 (Drug)

Oral Morphine Syrup

Active Comparator

Oral Morphine Syrup 2.5 ml ( 5 mg) in oral router that first time given after Breakthrough Pain is occurred

干预措施: Morphine (Drug)

结局指标

主要结局

Pain score

时间窗: after drug is given at 5 minutes

measure with numeric score from 0-10 point (maximum pain= 10 point)

次要结局

  • Neausea and vomiting(after drug is given at 5 minutes)
  • Ithching(after drug is given at 5 minutes)
  • Respiratory distress(after drug is given at 5 minutes)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验